Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post‐hoc analysis

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post‐hoc analysis

Abstract Aims/Introduction The etiology and treatment of type 2 diabetes might differ between specific populations. This post‐hoc exploratory analysis assessed the efficacy and safety of once‐weekly subcutaneous semaglutide vs comparators in Japanese individuals with type 2 diabetes in comparison wi...

Full description

Bibliographic Details
Main Authors: Eiichi Araki, Shinichi Harashima, Tomoyuki Nishida, Jiro Nakamura
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Journal of Diabetes Investigation
Subjects:
Treatment
Glucagon‐like peptide‐1 receptor
Glycated hemoglobin
Online Access:https://doi.org/10.1111/jdi.13905

Internet

https://doi.org/10.1111/jdi.13905

Similar Items